智通财经APP获悉，四环医药(00460)尾盘涨幅扩大逾9%，截至发稿，涨9.84%，报0.67港元，成交额4722.85万港元。
消息面上，4月1日，国家药品监督管理局医疗器械批准证明文件送达信息显示，四环医药旗下渼颜空间生物科技（吉林）有限公司的注射用聚己内酯微球面部填充剂获批。据悉，这是国内第三款获批的少女针。
此外，四环医药宣布，海南渼肤医疗器械(渼肤公司)的注册资本将由100万元人民币增加至5000万元，其中，公司非全资附属渼颜空间出资2550万元，海南特渼出资2350万元。目前，渼肤公司为海南特渼的全资附属公司。于增资完成后，渼肤公司将由渼颜空间及海南特渼分别持有51%及49%的股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.